Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457962 · ClinicalTrials.gov registry record
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
A clinical trial of Solid Tumors and Hematologic Malignancies, sponsored by Mayo Clinic.
- Active
- Registry status
- 14,266
- Enrollment target
- 1
- Study location
NCT02457962 is a study of Solid Tumors and Hematologic Malignancies that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 14,266 participants, above the 170-participant average among 125 other Solid Tumors trials with a reported enrollment target (8292% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02457962, a study of Solid Tumors and Hematologic Malignancies, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 14,266 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,266 participants |
| Start Date | 2015-04-23 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02457962
The ClinicalTrials.gov registry entry for NCT02457962 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 14,266 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 170-participant average among 125 other Solid Tumors trials with a reported enrollment target (8292% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT02457962 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02457962 about?
NCT02457962 is a clinical study titled "Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study". To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
What is the current status of trial NCT02457962?
This trial is currently active not recruiting. The enrollment target is 14,266 participants. The study started on 2015-04-23. Estimated completion is 2026-04.
What conditions does trial NCT02457962 study?
This clinical trial studies the following conditions: Solid Tumors, Hematologic Malignancies.
Who is sponsoring clinical trial NCT02457962?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02457962 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.